Literature DB >> 16815678

Epilepsy syndromes undetermined whether focal or generalized in infants.

Christian M Korff1, Douglas R Nordli.   

Abstract

PURPOSE: To describe the seizures in infants with epilepsy syndromes undetermined whether focal or generalized.
METHODS: This was a retrospective video-EEG study of seizures recorded at Children's Memorial Hospital (CMH), Chicago, IL, in infants diagnosed with epilepsy syndromes undetermined whether focal or generalized.
RESULTS: Of 69 infants with seizures recorded, 23 (33%) had epilepsies undetermined whether focal or generalized with both generalized and focal seizures, 17 of which (25% of the total) had epilepsies with both focal and generalized seizures not further specified. The predominant seizure type was spasms with focal seizures.
CONCLUSIONS: We propose several small modifications to the existing 1989 ILAE epilepsy syndrome classification: epilepsies with both focal and generalized seizures could be re-labeled "pleomorphic epilepsies" for simplicity and should include idiopathic and symptomatic subgroups. We believe these epilepsies are not uncommon in the group of infants with intractable seizures and may have yet to be discovered metabolic and genetic determinants.

Entities:  

Mesh:

Year:  2006        PMID: 16815678     DOI: 10.1016/j.eplepsyres.2005.11.013

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  2 in total

Review 1.  On the multiple roles of the voltage gated sodium channel β1 subunit in genetic diseases.

Authors:  Debora Baroni; Oscar Moran
Journal:  Front Pharmacol       Date:  2015-05-18       Impact factor: 5.810

2.  Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome.

Authors:  J Helen Cross; Ruchi Arora; Rolf A Heckemann; Roxana Gunny; Kling Chong; Lucinda Carr; Torsten Baldeweg; Ann-Marie Differ; Nicholas Lench; Sophie Varadkar; Tony Sirimanna; Evangeline Wassmer; Sally A Hulton; Milos Ognjanovic; Venkateswaran Ramesh; Sally Feather; Robert Kleta; Alexander Hammers; Detlef Bockenhauer
Journal:  Dev Med Child Neurol       Date:  2013-09       Impact factor: 5.449

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.